These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18661871)

  • 1. Design, development, and optimization of orally disintegrating tablets of etoricoxib using vacuum-drying approach.
    Patel D; Shah M; Shah S; Shah T; Amin A
    PDA J Pharm Sci Technol; 2008; 62(3):224-32. PubMed ID: 18661871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique.
    Gohel M; Patel M; Amin A; Agrawal R; Dave R; Bariya N
    AAPS PharmSciTech; 2004 Apr; 5(3):e36. PubMed ID: 15760070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of fast dissolving etoricoxib tablets prepared by sublimation technique.
    Patel DM; Patel MM
    Indian J Pharm Sci; 2008 Jan; 70(1):71-6. PubMed ID: 20390084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H; Taheri A; Homayouni A
    Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparative Study of Different Proportions of Superdisintegrants: Formulation and Evaluation of Orally Disintegrating Tablets of Salbutamol Sulphate.
    Kumar A; Saharan VA
    Turk J Pharm Sci; 2017 Apr; 14(1):40-48. PubMed ID: 32454593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
    Mostafa HF; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
    Gulsun T; Ozturk N; Kaynak MS; Vural I; Sahin S
    Pharmazie; 2017 Jul; 72(7):389-394. PubMed ID: 29441935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and evaluation of mouth dissolving tablets of the Etoricoxib.
    Chandira RM; Venkataeswarlu BS; Kumudhavalli MV; Debjitbhowmik ; Jayakar B
    Pak J Pharm Sci; 2010 Apr; 23(2):178-81. PubMed ID: 20363696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a superdisintegrant on disintegration of orally disintegrating tablets determined by simulated wetting test and
    Sutthapitaksakul L; Thanawuth K; Huanbutta K; Sriamornsak P
    Pharmazie; 2022 Oct; 77(10):287-290. PubMed ID: 36273260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
    Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats.
    Tawfeek HM; Faisal W; Soliman GM
    Pharm Dev Technol; 2018 Jun; 23(5):496-503. PubMed ID: 28489472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology.
    Zhang Y; Li Z; Tang H; Ren W; Gao X; Sun Y; Zhao QX; Wang F; Liu J
    Drug Dev Ind Pharm; 2020 Jan; 46(1):42-49. PubMed ID: 31794271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic screening of compressed ODT excipients: cellulosic versus non-cellulosic.
    Al-Khattawi A; Iyire A; Dennison T; Dahmash E; Bailey CJ; Smith J; Rue P; Mohammed AR
    Curr Drug Deliv; 2014; 11(4):486-500. PubMed ID: 24655059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.
    Douroumis DD; Gryczke A; Schminke S
    AAPS PharmSciTech; 2011 Mar; 12(1):141-51. PubMed ID: 21181510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, development, and optimization of immediate release nateglinide tablets by factorial design.
    Pani NR; Nath LK; Bhunia B
    Drug Discov Ther; 2010 Dec; 4(6):453-8. PubMed ID: 22491311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of polyglycolized glycerides in protection of amorphous form of etoricoxib during compression.
    Shimpi S; Mahadik K; Takada K; Paradkar A
    Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1448-51. PubMed ID: 17917287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of promethazine theoclate fast dissolving tablet using pore forming technology by 3-factor, 3-level response surface-full factorial design.
    Sharma S; Sharma N; Das Gupta G
    Arch Pharm Res; 2010 Aug; 33(8):1199-207. PubMed ID: 20803123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.